You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR PHENAZINE-35


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for PHENAZINE-35

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02473042 ↗ Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) Active, not recruiting M.D. Anderson Cancer Center N/A 2016-02-01 The goal of this clinical research study is to learn if light electrical stimulation to the wrist area during surgery is feasible in women having breast surgery.
NCT04852510 ↗ Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin Completed Saudi German Hospital - Madinah Phase 2/Phase 3 2019-02-01 Objective: To investigate the potential benefit of adding Thymoquinone to Metformin in alleviating symptoms of polycystic ovarian syndrome. Methods: 207 overweight and obese PCOS Patients were divided into two groups. Patients in Group A, received Metformin 500 mg three times daily for 6 months. Patients in Group B, received a combination of Metformin 500 mg and Thymoquinone in the form of Black Cumin oil 500 mg capsules three times daily for 6 months. Follow up was done after 3 and 6 months from the beginning of the study for evaluation of menstrual cycle pattern, body mass index, Waist circumference, Hip circumference, and Waist / Hip ratio, Oral glucose tolerance test, Glycosylated Hemoglobin A1C, Superoxide dismutase activity and Malondialdehyde concentration.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for PHENAZINE-35

Condition Name

Condition Name for PHENAZINE-35
Intervention Trials
Breast Cancer 1
Polycystic Ovary Syndrome (PCOS) 1
Post-Operative Nausea and Vomiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for PHENAZINE-35
Intervention Trials
Polycystic Ovary Syndrome 1
Vomiting 1
Postoperative Nausea and Vomiting 1
Nausea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for PHENAZINE-35

Trials by Country

Trials by Country for PHENAZINE-35
Location Trials
United States 1
Saudi Arabia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for PHENAZINE-35
Location Trials
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for PHENAZINE-35

Clinical Trial Phase

Clinical Trial Phase for PHENAZINE-35
Clinical Trial Phase Trials
Phase 2/Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for PHENAZINE-35
Clinical Trial Phase Trials
Active, not recruiting 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PHENAZINE-35

Sponsor Name

Sponsor Name for PHENAZINE-35
Sponsor Trials
M.D. Anderson Cancer Center 1
Saudi German Hospital - Madinah 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for PHENAZINE-35
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.